Dehydroepiandrosterone Supplementation for Poor Responder Patients During in Vitro Fertilization Treatment

Clalit Health Services

Status: Completed

Conditions: Ovarian Stimulation

Treatments: Drug: dehydroepiandrosterone crystalline fine powder

Study type: Interventional

Funder types: Other

Identifiers

NCT01145144

mmc07204-2006ctil

Details and patient eligibility

About

The aim of this study was to evaluate the effect of dehydroepiandrosterone supplementation on in vitro fertilization performance and outcome among poor-responder patient.

Sex: Female

Ages: 18 to 42 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• previous poor response to ovarian stimulation in IVF.

Exclusion criteria

• patients over the age of 42
• patients who received DHEA at any time.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)

---

0 participants in 2 patient groups

DHEA supplementation

Experimental group

Description:

DHEA was added to induction of ovulation by recombinant FSH and recombinant LH, in IVF long protocol

Treatment:

Drug: dehydroepiandrosterone crystalline fine powder

only induction of ovulation by same long protocol without DHEA

No Intervention group